02-313-21 Me. Code R. § IV

Current through 2024-51, December 18, 2024

Section 313-21-IV - Controlled Substances Contract

Suggested elements of a controlled substance contract are as follows:

1. Specifies that the clinician is the single source of controlled substances;

2. May specify the pharmacy;

3. Provides written, informed consent to release contract to local emergency departments and pharmacies;

4. If written consent is given for release to local emergency departments and/or pharmacies, consent is also being given to the other clinicians and providers such as pharmacists to report violations of the contract back to the prescribing clinician;

5. Specifies that if the clinician becomes concerned that there has been illegal activity, the clinician may notify the proper authorities;

6. Provides that if the clinician has obtained a written release, ER personnel and other providers shall report violations of the contract back to the doctor who prescribed the controlled substance(s);

7. Specifies that a violation of the contract will result in a tapering and discontinuation of the narcotics prescription;

8. Specifies that a risk of chronic narcotics treatment is physical dependence (as defined);

9. Specifies that a risk of chronic narcotics treatment is addiction (as defined);

10. Specifies that it is the responsibility of the patient to be discreet about possessing narcotics and keeping medications in an inaccessible place so that they may not be stolen;

11. If the patient violates the terms of the contract, the violation should be documented. The clinician response to the violation should be documented, as well as the rationale of and changes in the treatment plan;

12. Clinician may consider "fill only at _________________ pharmacy" on the prescription form;

13. Specifies use of urine/serum medications levels screening when appropriate; and

14. Specifies use of a pill count when appropriate.

02-313 C.M.R. ch. 21, § IV